ZNG Medical
ZNG Medical
As Southeast Asia's largest economy, Indonesia is currently facing a significant public health challenge with the rising prevalence of diabetes. According to the International Diabetes Federation (IDF), Indonesia ranks among the top countries globally for the number of adults living with diabetes. This demographic shift has catalyzed a massive demand for reliable, user-friendly, and cost-effective delivery systems like insulin pens.
Industrial Landscape: The Indonesian medical device market is undergoing a transformation driven by the government's "Making Indonesia 4.0" initiative and the expansion of the National Health Insurance (BPJS Kesehatan). This has created a fertile ground for high-quality insulin pen suppliers who can meet both the volume and the strict regulatory standards (HALAL and BPJS requirements) set by the Ministry of Health.
Our insulin delivery solutions are designed with the Indonesian patient in mind. From the bustling urban centers of Jakarta and Surabaya to the remote areas of Kalimantan, our products are engineered for:
Zhejiang ZNG Medical, founded in 1996, stands as a beacon of excellence in the medical device industry. With nearly three decades of experience, we have specialized in the research, development, and mass production of high-precision injection products. Our entry into the Indonesian market is backed by global certifications including ISO 9001 and CE, ensuring that every product we export meets the rigorous safety demands of international healthcare.
Our mission is simple: To empower public health by listening to the specific needs of medical professionals and patients. In Indonesia, this means providing affordable yet technologically advanced insulin pens that bridge the gap between diagnosis and effective management.
The industry is moving towards "Smart Injection" systems. We are currently observing several key trends in the Indonesian archipelago:
Environmental sustainability and long-term cost-efficiency are driving Indonesian clinics to prefer high-quality metal reusable pens over disposable ones.
Removing the "stigma" of diabetes through colorful, sleek, and discreet pen designs—especially popular among the younger Indonesian demographic.
Demand for ultra-fine needles (31G, 32G) is increasing to provide a "painless" experience, which is crucial for patient compliance in local communities.
Exporting to Indonesia requires a deep understanding of the Lembaga Sertifikasi Produk (LSPro) and local distribution laws. ZNG Medical ensures that all components, from the 3ml prefilled cartridge housings to the sterile pen needles, are manufactured in cleanroom environments that exceed industry standards. Our needles feature a proprietary lubrication technology to ensure the smoothest penetration possible.
We provide end-to-end OEM services, allowing Indonesian pharmaceutical brands to launch their own branded insulin delivery systems with minimal lead time.
Producing Cannula
Injection Molding
Precision Assembling
Sterilization by EO
Partner with ZNG Medical for reliable manufacturing and global expertise.
Send Inquiry Now
